Insider · CIK 0001248094

PRICE FREDRIC D

Reports to the SEC for 3 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001248094

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-03-03	Pharmasset IncM Exercise/Conversion	Director	MExercise/Conversion	+1,668 sh	$5.45	+$9,082.26	30,666
2010-03-03	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,668 sh	—	—	0.67
2009-12-04	Pharmasset IncM Exercise/Conversion	Director	MExercise/Conversion	+1,666 sh	$5.45	+$9,071.37	28,998
2009-12-04	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,666 sh	—	—	1,668.67
2009-10-14	Pharmasset IncStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2009-09-02	Pharmasset IncM Exercise/Conversion	Director	MExercise/Conversion	+1,666 sh	$5.45	+$9,071.37	27,332
2009-09-02	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,666 sh	—	—	3,334.67
2009-06-01	Pharmasset IncM Exercise/Conversion	Director	MExercise/Conversion	+21.7K sh	$5.45	+$118K	25,666
2009-06-01	Pharmasset IncStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−21.7K sh	—	—	5,000.67
2009-03-24	Pharmasset IncA Award	Director	AAward	+2,000 sh	—	—	4,000
2008-10-29	Pharmasset IncStock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2008-09-24	Pharmasset IncA Award	Director	AAward	+2,000 sh	—	—	2,000
2007-10-10	Pharmasset IncStock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2007-06-04	Omrix Biopharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+49K sh	$6.19	+$303K	56,000
2007-06-04	Omrix Biopharmaceuticals, Inc.S Sale	Director	SSale	−49K sh	$33.80	−$1.66M	7,000
2007-06-04	Omrix Biopharmaceuticals, Inc.Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−49K sh	—	—	60,091
2007-05-31	Omrix Biopharmaceuticals, Inc.A Award	Director	AAward	+2,000 sh	—	—	7,000
2007-05-31	Omrix Biopharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	0
2006-06-27	Omrix Biopharmaceuticals, Inc.Stock OptionA Award	Director	AAward	+11K sh	—	—	120,091
2003-10-31	BMRNBIOMARIN PHARMACEUTICAL INCA Award	Director, Chief Executive Officer	AAward	+39.3K sh	—	—	64,285
2003-10-31	BMRNBIOMARIN PHARMACEUTICAL INC · Stock Options (right to buy)A Award	Director, Chief Executive Officer	AAward	+500K sh	—	—	1,323,288

Recent filings

Accepted (ET)
Mar 44
PRICE FREDRIC D0001192482-10-000030
SEC(opens sec.gov)
Dec 74
PRICE FREDRIC D0001192482-09-000311
SEC(opens sec.gov)
Oct 264
Pharmasset Inc0001192482-09-000288
SEC(opens sec.gov)
Sep 34
PRICE FREDRIC D0001192482-09-000249
SEC(opens sec.gov)
Jun 24
PRICE FREDRIC D0001192482-09-000155
SEC(opens sec.gov)
Mar 264
PRICE FREDRIC D0001192482-09-000073
SEC(opens sec.gov)
Nov 194
PRICE FREDRIC D0001192482-08-000420
SEC(opens sec.gov)
Sep 304/A
Pharmasset Inc0001192482-08-000335
SEC(opens sec.gov)
Jan 184
Pharmasset Inc0001192482-08-000044
SEC(opens sec.gov)
Jun 54
Omrix Biopharmaceuticals, Inc.0001209191-07-035138
SEC(opens sec.gov)
Jun 14
Omrix Biopharmaceuticals, Inc.0001209191-07-034346
SEC(opens sec.gov)
Jun 294
PRICE FREDRIC D0001209191-06-038607
SEC(opens sec.gov)
Nov 34
PRICE FREDRIC D0001048477-03-000081
SEC(opens sec.gov)

Companies

Address

303A COLLEGE ROAD EAST

PRINCETON, NJ, 08540